These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15569993)

  • 1. A clinicobiological model predicting survival in medulloblastoma.
    Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
    Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
    Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
    Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
    Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
    Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
    Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
    J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
    de Haas T; Hasselt N; Troost D; Caron H; Popovic M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D; Baas F; Versteeg R; Kool M
    Clin Cancer Res; 2008 Jul; 14(13):4154-60. PubMed ID: 18593994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
    Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
    J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
    Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
    J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
    Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
    Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
    Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
    Schüller U; Schober F; Kretzschmar HA; Herms J
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
    Min HS; Lee YJ; Park K; Cho BK; Park SH
    Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
    Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
    Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
    Kröger N; Milde-Langosch K; Riethdorf S; Schmoor C; Schumacher M; Zander AR; Löning T
    Clin Cancer Res; 2006 Jan; 12(1):159-68. PubMed ID: 16397038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.
    Pingoud-Meier C; Lang D; Janss AJ; Rorke LB; Phillips PC; Shalaby T; Grotzer MA
    Clin Cancer Res; 2003 Dec; 9(17):6401-9. PubMed ID: 14695141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
    Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
    Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
    Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.